Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Fractures, Bone

glucose, (beta-d)-isomer has been researched along with Fractures, Bone in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's13 (86.67)24.3611
2020's2 (13.33)2.80

Authors

AuthorsStudies
Jackson, K; Moseley, KF1
Pan, H; Shen, J; Zhao, B; Zhao, J1
Harindhanavudhi, T; Ruanpeng, D; Sangtian, J; Ungprasert, P1
Bilezikian, JP; Hanif, W; Keerthy, D; Kotsa, K; Nirantharakumar, K; Tahrani, AA; Thayakaran, R; Thomas, GN; Toulis, KA1
Kaspers, S; Kohler, S; Salsali, A; Woerle, HJ; Zeller, C1
Eliasson, B; Franzén, S; Gudbjörnsdottir, S; Hveem, K; Jonasson, C; Melbye, M; Pasternak, B; Svanström, H; Svensson, AM; Ueda, P1
Kaneko, M; Narukawa, M1
Aubrey-Bassler, K; Chibrikov, E; Curnew, D; Donnan, JR; Gamble, JM; Grandy, CA; Hache, J; Johnston, K; Marra, CA; Nguyen, H; Swab, M1
Blau, JE; Rother, KI; Taylor, SI1
Johnsson, E; Johnsson, K; Mansfield, TA; Parikh, SJ; Ptaszynska, A; Yavin, Y1
Fioretto, P; Johnsson, E; Mansfield, TA; Parikh, S; Ptaszynska, A; Yavin, Y1
Faillie, JL1
Hsu, YH; Li, DD; Song, YQ; Tang, HL; Wang, TS; Zhai, SD; Zhang, JJ1
Scheen, AJ1
Mannucci, E; Monami, M1

Reviews

8 review(s) available for glucose, (beta-d)-isomer and Fractures, Bone

ArticleYear
Diabetes and Bone Fragility: SGLT2 Inhibitor Use in the Context of Renal and Cardiovascular Benefits.
    Current osteoporosis reports, 2020, Volume: 18, Issue:5

    Topics: Accidental Falls; Benzhydryl Compounds; Bone Density; Bone Remodeling; Calcium; Canagliflozin; Diabetes Mellitus, Type 2; Fractures, Bone; Glucosides; Humans; Phosphates; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors

2020
Sodium-glucose cotransporter 2 (SGLT2) inhibitors and fracture risk in patients with type 2 diabetes mellitus: A meta-analysis.
    Diabetes/metabolism research and reviews, 2017, Volume: 33, Issue:6

    Topics: Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus, Type 2; Fractures, Bone; Glucosides; Humans; Randomized Controlled Trials as Topic; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors

2017
Analysis of Fractures in Patients With Type 2 Diabetes Treated With Empagliflozin in Pooled Data From Placebo-Controlled Trials and a Head-to-Head Study Versus Glimepiride.
    Diabetes care, 2018, Volume: 41, Issue:8

    Topics: Adult; Aged; Benzhydryl Compounds; Bone Density; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Female; Fractures, Bone; Glucosides; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Sulfonylurea Compounds

2018
Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis.
    BMJ open, 2019, 02-01, Volume: 9, Issue:1

    Topics: Acute Kidney Injury; Amputation, Surgical; Benzhydryl Compounds; Canagliflozin; Diabetic Ketoacidosis; Fractures, Bone; Glucosides; Humans; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Urinary Tract Infections

2019
Pharmacological aspects of the safety of gliflozins.
    Pharmacological research, 2017, Volume: 118

    Topics: Animals; Benzhydryl Compounds; Fractures, Bone; Glomerular Filtration Rate; Glucosides; Humans; Hypoglycemic Agents; Ketosis; Lipids; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2 Inhibitors

2017
Lack of evidence for a harmful effect of sodium-glucose co-transporter 2 (SGLT2) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta-analysis of randomized controlled trials.
    Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:12

    Topics: Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus, Type 2; Fractures, Bone; Glucosides; Humans; Hypoglycemic Agents; Incidence; Network Meta-Analysis; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors

2016
SGLT2 Inhibitors: Benefit/Risk Balance.
    Current diabetes reports, 2016, Volume: 16, Issue:10

    Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Fractures, Bone; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Ketosis; Risk Assessment; Sodium-Glucose Transporter 2 Inhibitors

2016
Bone Fractures with Sodium-Glucose Co-transporter-2 Inhibitors: How Real is the Risk?
    Drug safety, 2017, Volume: 40, Issue:2

    Topics: Animals; Benzhydryl Compounds; Bone Density; Canagliflozin; Drug Labeling; Fractures, Bone; Glucosides; Humans; Hypoglycemic Agents; Parathyroid Hormone; Risk; Sodium-Glucose Transporter 2 Inhibitors; United States; United States Food and Drug Administration; Vitamin D

2017

Other Studies

7 other study(ies) available for glucose, (beta-d)-isomer and Fractures, Bone

ArticleYear
Do sodium-glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real-world study.
    Journal of diabetes investigation, 2021, Volume: 12, Issue:8

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bayes Theorem; Benzhydryl Compounds; Bone Density; Canagliflozin; Data Mining; Female; Fractures, Bone; Glucosides; Hospitalization; Humans; Hypoglycemic Agents; Male; Middle Aged; Pharmacovigilance; Retrospective Studies; Risk Factors; Sex Factors; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Young Adult

2021
Initiation of dapagliflozin and treatment-emergent fractures.
    Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:4

    Topics: Aged; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Fractures, Bone; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Risk Factors

2018
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.
    BMJ (Clinical research ed.), 2018, Nov-14, Volume: 363

    Topics: Adult; Amputation, Surgical; Benzhydryl Compounds; Canagliflozin; Cohort Studies; Denmark; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Female; Fractures, Bone; Glucosides; Humans; Hypoglycemic Agents; Logistic Models; Male; Middle Aged; Pancreatitis; Propensity Score; Sodium-Glucose Transporter 2 Inhibitors; Sweden; Urinary Tract Infections; Venous Thromboembolism

2018
Effects of Sodium-glucose Cotransporter 2 Inhibitors on Amputation, Bone Fracture, and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Using an Alternative Measure to the Hazard Ratio.
    Clinical drug investigation, 2019, Volume: 39, Issue:2

    Topics: Amputation, Surgical; Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus, Type 2; Female; Fractures, Bone; Glucosides; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors

2019
Possible adverse effects of SGLT2 inhibitors on bone.
    The lancet. Diabetes & endocrinology, 2015, Volume: 3, Issue:1

    Topics: Benzhydryl Compounds; Fractures, Bone; Glucosides; Humans; Hypoglycemic Agents; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors

2015
Osmotic diuresis with SGLT2 inhibition: analysis of events related to volume reduction in dapagliflozin clinical trials.
    Postgraduate medicine, 2016, Volume: 128, Issue:4

    Topics: Age Factors; Aged; Benzhydryl Compounds; Blood Pressure; Blood Urea Nitrogen; Diuresis; Female; Fractures, Bone; Glomerular Filtration Rate; Glucosides; Humans; Hypoglycemic Agents; Hypotension, Orthostatic; Hypovolemia; Incidence; Male; Middle Aged; Osmosis; Placebos; Polyuria; Randomized Controlled Trials as Topic; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors

2016
Long-Term Safety of Dapagliflozin in Older Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Phase IIb/III Studies.
    Drugs & aging, 2016, Volume: 33, Issue:7

    Topics: Adult; Aged; Benzhydryl Compounds; Cardiovascular Diseases; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Female; Fractures, Bone; Glucosides; Humans; Hypoglycemia; Hypoglycemic Agents; Kidney; Male; Middle Aged; Risk Factors; Safety; Urinary Tract Infections

2016